Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits

Cardiovascular Drugs and Therapy

Volumn 25, Issue 2, 2011, Pages 119-131

  Akar, Fatma ^a   Pektas, M Bilgehan ^a   Tufan, Can ^a   Soylemez, Selen ^a   Sepici, Aylin ^a   Ulus, A Tulga ^b   Gokalp, Burcu ^a   Ozturk, Kamile ^c   Surucu, H Selcuk ^d  

^a GAZI UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c AKSARAY UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alloxan; Diabetic rabbits; Endothelial and vascular function; Insulin; Nitric oxide; Resveratrol; Superoxide

Indexed keywords

ACETYLCHOLINE; GLUCOSE; INSULIN; LIPID; LIPID PEROXIDE; NITRATE; NITRITE; PHENYLEPHRINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESVERATROL; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; VASOPROTECTIVE EFFECT;

ACETYLCHOLINE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ESTROGENS; INSULIN; LIPID PEROXIDES; LIPIDS; MALE; NADP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RABBITS; STILBENES; SUPEROXIDE DISMUTASE; TESTOSTERONE; TIME FACTORS; VASCULAR DISEASES;

EID: 79958243683     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-010-6255-7     Document Type: Article

References (40)

1. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-74. (Pubitemid 30453529)
2. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:E14-22.
3. Oak JH, Cai H. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes. 2007;56:118-26.
4. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signaling. Cardiovasc Res. 2009;82:9-20.
5. Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol. 2002;61:294-302. (Pubitemid 34112803)
6. Coskun B, Soylemez S, Parlar AI, Ulus AT, Katircioglu SF, Akar F. Effect of resveratrol on nitrate tolerance in isolated human internal mammary artery. J Cardiovas Pharmacol. 2006;47:437-45. (Pubitemid 44309698)
7. Chow S-E, Hshu Y-C, Wang J-S, Chen J-K. Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol. 2007;102:1520-7. (Pubitemid 46571048)
8. Soylemez S, Gurdal H, Sepici A, Akar F. The effect of long-term resveratrol treatment on relaxation to estrogen in aortae from male and female rats: role of nitric oxide and superoxide. Vasc Pharmacol. 2008;49:97-105.
9. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending lifespan. Cell Metab. 2008;8:157-68.
10. Csiszar A, Labinskyy N, Podlutsky A, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol. 2008;294:H2721-35.
11. Soylemez S, Sepici A, Akar F. Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats. Cardiovasc Drugs Ther. 2009;23:449-58.
12. Zhang H, Zhang J, Ungvari Z, Zhang C. Resveratrol improves endothelial function. Role of TNF and vascular oxidative stress. Arterioscler Thromb Vasc Biol. 2009;29:1164-71.
13. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-42.
14. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109-22. (Pubitemid 44894520)
15. Su H-C, Hung L-M, Chen J-K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2006;290:E1339-46.
16. Chi TC, Chen WP, Chi TL, Kuo TF, Lee SS, Cheng JT, et al. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci. 2007;80:1713-20.
17. Schmatz R, Schetinger MR, Spanevello RM, et al. Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. Life Sci. 2009;84:345-50.
18. Orimo M, Minamino T, Miyauchi H, et al. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol. 2009;29:889-94.
19. Skatchkov MP, Sperling D, Hink U, Mulsch A, Harrison DG, Sindermann I. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun. 1999;254:319-24. (Pubitemid 29290398)
20. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493-506. (Pubitemid 44136961)
21. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest. 1990;85:929-32. (Pubitemid 20087498)
22. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose impairs endothelium-dependent relaxations by activating protein kinase C. J Clin Invest. 1991;87:1643-8.
23. Zanetti M, Sato J, Katusic ZS, O'Brien T. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Am J Physiol Heart Circ Physiol. 2001;280:H2516-23.
24. Shah DI, Singh M. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats. Mol Cell Biochem. 2007;295:65-74. (Pubitemid 46157988)
25. Palsamy P, Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother. 2008;62:598-605.
26. Chen W-P, Chi T-C, Chuang L-M, Su M-J. Resveratrol enhances insulin secretion by blocking KATP and KV channels of beta cells. Eur J Pharmacol. 2007;568:269-77. (Pubitemid 46976913)
27. Silan C. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol Pharm Bull. 2008;31:897-902. (Pubitemid 351731986)
28. Campos-Toimil M, Elíes J, Orallo F. Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells. Mol Nutr Food Res. 2005;49:396-404. (Pubitemid 40780388)
29. Campos-Toimil M, Elíes J, Alvarez E, Verde I, Orallo F. Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes. Eur J Pharmacol. 2007;577:91-9. (Pubitemid 350001288)
30. Jager U, Nguyen-Doung H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneim Forsch Drug Res. 1999;49:207-11. (Pubitemid 29142817)
31. Bolego C, Cignarella A, Zancan V, Pinna C, Zanardo R, Puglisi L. Diabetes abolishes the vascular protective effects of estrogen in female rats. Life Sci. 1999;64:741-9. (Pubitemid 29098968)
32. Rush JWE, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med. 2007;232:814-22. (Pubitemid 46827824)
33. Miatello R, Vázquez M, Renna N, Cruzado M, Zumino AP, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens. 2005;18:864-70. (Pubitemid 40745275)
34. Schiller NK, Timothy AM, Chen IL, et al. Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits. Am J Physiol Heart Circ Physiol. 1999;277:H740-8.
35. Csiszar A, Labinskyy N, Pinto JT, et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol. 2009;297:H13-20.
36. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009;297: H1876-81.
37. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol. 2010;299:H18-24.
38. Ungvari Z, Orosz Z, Rivera A, et al. Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol. 2007;292:H2417-24.
39. Csiszar A, Labinskyy N, Jimenez R, et al. Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev. 2009;130:518-27.
40. Wang Y, Lee KW, Chan FL, Shiuan CS, Leung LK. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci. 2006;92:71-7. (Pubitemid 43985791)